IBT.BInfant Bacterial Therapeutics ABIBT.B info
$3.13info-1.71%24h
Global rank
Market cap$40.69M
Change 7d-5.22%
YTD Performance-61.67%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Infant Bacterial Therapeutics AB (IBT.B) Stock Overview

    Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent or treat rare diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, to prevent necrotizing enterocolitis, as well as to improve feeding tolerance affecting premature infants. It is also developing IBP-1016 for the treatment of gastroschisis, a rare and severe disease in infants. The company was incorporated in 2011 and is based in Stockholm, Sweden.

    IBT.B Stock Information

    Symbol
    IBT.B
    Address
    Bryggargatan 10Stockholm, 111 21Sweden
    Founded
    -
    Trading hours
    -
    Website
    https://www.ibtherapeutics.com
    Country
    πŸ‡ΈπŸ‡ͺ Sweden
    Phone Number
    46 7 62 19 37 38

    Infant Bacterial Therapeutics AB (IBT.B) Price Chart

    -
    Value:-

    Infant Bacterial Therapeutics AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.13
    N/A
    Market Cap
    $40.69M
    N/A
    Shares Outstanding
    13.02M
    N/A
    Employees
    8.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org